FDA approves Lilly’s Onswik for type 2 diabetes in adults

Friday, September 25, 2026Salong DebbarmaView original

The US FDA has approved Eli Lilly and Company’s Onswik, a once-weekly basal insulin injection for adults with type 2 diabetes.

Read the full article on the original site.